Amiodarone Market Top Leading Players with Strategies and Forecast 2028

The global amiodarone market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Amiodarone is also known as an anti-arrhythmic drug. It is a medication that is used to treat certain types of serious irregular heartbeat such as persistent ventricular fibrillation/tachycardia. Additionally, It restores normal heart rhythm and supports to maintain a regular steady heartbeat and works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. The major factor driving the demand for amiodarone is the rising incidence of cardiac arrest across the globe.

According to the American Heart Association report, Heart and Stroke Statistics - 2022 Update, cardiac arrest remains a public health crisis with more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the US, out of which nearly 90% of them fatal. Additionally, the incidence of EMS-assessed non-traumatic OHCA in people of any age is estimated to be 356,461, or nearly 1,000 people each day. Hence, the increasing prevalence of cardiac arrest is driving the demand for amiodarone for treatment as it stabilizes the heartbeat which in turn is driving the growth of the market.

To Request a Sample of our Report on Amiodarone Market: https://www.omrglobal.com/request-sample/amiodarone-market

Some major players in the market include Sanofi SA, Mylan NV, and GlaxoSmithKline plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in July 2020, Unichem Laboratories announced that it has received approval from the US FDA for Amiodarone tablets, the generic version of Wyeth Pharmaceuticals Inc's Cordarone tablets for the treatment of an irregular heartbeat.

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Sanofi SA, Mylan NV, and GlaxoSmithKline plc, among others.

(Get 15% Discount on Buying this Report)

A full Report of Amiodarone Market is Available @ https://www.omrglobal.com/industry-reports/amiodarone-market

Global Amiodarone Market Report by Segment

By Type

· Tablet

· Capsule

· Injection

By Application

· Cardiac Arrest

· Ventricular Tachycardia

· Atrial Fibrillation

· Others

Global Amiodarone Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.